Archive for the ‘vaccines’ Category

Response to the Proposed Monoclonal Antibody Injection to Prevent Lyme Disease

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/13944776?tk=-q6Qjp9U5xBsfKfijcGzoHsOghM6B0xXtori7lxgItI&utm_source=petition_update&utm_medium=email

Carl Tuttle, a Lyme activist from New Hampshire, has written a letter to Dr. Klempner regarding the safety of the monoclonal antibody injection proposed to prevent Lyme Disease.

  1. There is no safety window to protect against infection. According to Dr. Burgdorfer who stated in 1999 that about 5-10% of ticks that are carrying Lyme have a systemic infection and have the disease already in their salivary glands and can transmit infection immediately.
  2.  There is no protection from blood transmission due to blood transfusion.
  3. It can not protect against transmission by feces, urine, or tick-excretes.
  4. It will not protect sexual transmission.
  5. It will not protect from congenital transmission. 28 Peer-Reviewed Studies http://home.comcast.net/~runagain/Congenital%20Transmission%20of%20Lyme.doc

New Research to Prevent Lyme Disease

http://www.nbcnews.com/health/health-news/lyme-disease-treatment-would-prevent-infection-researchers-say-n441946

Dr. Mark Klempner of the University of Masachusetts’ nonprofit vaccine development arm, MassBiologics, states that they are working on a monoclonal antibody that specifically targets Lyme-causing bacteria that purports the highest level of immunity.

Using genetically engineered mice with human immune system genes, they immunized the mice using Borrelia bacteria and then collected the antibodies the mice produced. They identified four to be potent against multiple strains of Borrelia, the Lyme disease causing bacteria.

When testing the antibodies produced, a single injection protected them from a large dose of Borrelia even after several infected ticks bit the mice.

And while U.S. Biologic is working on a vaccine for mice, produced in pellets resembling kibble, Klemner states emphatically that their monoclonal antibody is not a vaccine, instead it stimulates the immune system to ward off infection.

Monoclonal antibody drugs have been used for various diseases including cancer. It is similar in approach to gamma globulin shots that were used to try and prevent tuberculosis and hepatitis.

The company is hopeful to start testing in humans next year.